ophthalmology innovation showcase - cassini
Post on 15-Apr-2017
585 Views
Preview:
TRANSCRIPT
1
The integrated ecosystem of today’s ophthalmic practice
Cassini Presentation - COMPANY CONFIDENTIAL – April 2016
2
Growing the premium cataract channel
2015: Toric IOLs accounted for 3.7% of all IOLs Implanted Worldwide1
… it could be 50%2
1 Source: MarketScope report 2015 2 Source: Hill Distribution Data. Provided courtesey of Dr. Warren Hill
3
Integrated ecosystem in cataract surgery:Seamless interaction between clinic and OR
1
Pre Op Diagnostics &IOL selection
23
4
Post Op Analysis &SIA management
PatientRefractive Outcome
SurgeonResults & Efficiency
Femto enabled AI’s
Guidance &verification
4
1
23
4
Cassini integrated technology makes our partners more successful
Erik-Jan WorstCEO & President, Ophtec
“The combined offering of Cassini with Ophtec’s Precizon Toric IOL has allowed us to grow our market share and help our customers with a total astigmatism management solution"
Denise ViscoEyes of York, York, PA
“The addition of Cassini and Streamline has provided such great, predictable outcomes that I use arcuate incisions on most of my patients with less than 1.7D. This improves efficiency, reduces costs and increases conversion of patients to the premium channel”
Cassini Total Corneal AstigmatismGPS-like data from anterior & posterior cornea
Multi-colored LED point-to-point ray tracing
2nd Purkinje point-to-point ray tracing technology
• Retrospective chart review• 35 consecutive cases with toric IOL
implant• Preoperative measurements
oCassini TCA based toric IOL axis and power selection
• Postoperative residual refractive astigmatism
Cassini Outcome StudyDr. Elizabeth Yeu, Virginia Eye Consultants
Astigmatism Correction with Cassini TCAPre-Op Total Corneal Astigmatism 95% Limits of
agreementn = 35
Astigmatism Correction with Cassini TCAPost-Op Residual Astigmatism 95% Limits of
agreementn = 35
Cassini TCA v ORA – published data
ORA - Hatch et al JRS 2015
< 0.5Dn = 37
50%
75%
100%
94.2%
82.1%78.0%
Lenstar + Barrett
Nomogram < 0.5Dn = 28
Cassini TCA < 0.5Dn = 35
• Physician owned ASCs treat about 1000 pts/ year1
• High-volume centers have about 20% conversion to toric IOL 200 patients
• Total cost of enhancement is about $2,000.00– Tangibles and intangibles
1 Source: MarketScope report 2013; 2 Source: Hatch et al. Journal of Refractive Surgery April 2015; 3 Based on assumed enhancement costs $2.000 per patient; 4 Retrospective study from Elizabeth Yeu – Cassini data on file
IOL selection with ORA2
• 78% within 0.5D RRA
• 44 Patients > 0.5D RRA
• Potential enhancement cost $ 88,000.003
IOL selection with Cassini TCA4
• 94% within 0.5D RRA
• Only 12 patients > 0.5D RRA
• Potential enhancement cost $ 24,000.003
Economics of getting it right
11
top related